Barclays’s Cocrystal Pharma COCP Stock Holding History
Bought
Maintained
Sold
Other funds holding COCP
Barclays's COCP Position: Q3 2026 in Review
Barclays sold out of Cocrystal Pharma (COCP) in Q3 2026, closing a stake of 42 shares — an estimated $44 sold.
Barclays first reported a position in COCP in Q1 2021 and held it in 6 quarters. The position peaked at $28K in Q3 2021. 25 funds tracked by Wall St. Rank hold COCP as of Q3 2026.
- Barclays reported no remaining Cocrystal Pharma position as of Q3 2026 after selling out during the quarter.
- Barclays sold 42 Cocrystal Pharma shares in Q3 2026, an estimated $44.
- Barclays first reported a position in Cocrystal Pharma in Q1 2021 and held it in 6 quarters.
- Barclays's Cocrystal Pharma position peaked at $28K in Q3 2021.
- 25 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.